Ardx stock discussion

Ardelyx, Inc. (ARDX) Stock Price, Quote, History & News ... Find the latest Ardelyx, Inc. (ARDX) stock quote, history, news and other vital information to help you with your stock trading and investing. Why Ardelyx Is Soaring Today | The Motley Fool

It also develops RDX013, a small molecule potassium secretagogue program for the treatment of patients with hyperkalemia. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was founded in 2007 and is headquartered in Fremont, California. Ardelyx (NASDAQ:ARDX) - Why Are Shares Of Ardelyx Ripping ... Sep 04, 2019 · Shares of Ardelyx Inc (NASDAQ: ARDX) were advancing strongly on above-average volume Tuesday following a clinical trial readout from the company.. What Happened. Ardelyx announced positive results Ardelyx, Inc. (ARDX) Earnings Report | Seeking Alpha

See what is new at ARDX! Norfolk, VA, February 21, 2019 – ARDX, a leading government healthcare management and technology consulting firm, welcomes Tuan …

in conjunction with a series of project-organized induction courses and discussion meetings. The questionnaires were administered according to the following  Ardelyx, Inc. (ARDX) Stock Forum & Discussion - Yahoo Finance Find the latest Ardelyx, Inc. (ARDX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. ARDX Ardelyx — Stock Price and Discussion | Stocktwits Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. Ardelyx, Inc. (ARDX) Stock Price, Quote, History & News ...

View Ardelyx, Inc. ARDX investment & stock information. Get the latest Ardelyx, Inc. ARDX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

ARDX Stock Price, Forecast & News (Ardelyx) | MarketBeat Ardelyx's stock was trading at $5.98 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ARDX stock has decreased by 5.3% and is now trading at $5.6650. View which stocks have been mosted impacted by Coronavirus. ARDX (MC $155 M) FDA Decision for IBS-C Drug on September ... FDA Decision for IBS-C Drug (irritable bowel syndrome with constipation) on September 12, 2019 and Phase 3 readout of the AMPLIFY clinical trial for the treatment of Hyperphosphatemia also in Q3 2019 . Tenapanor has over $500 million commercial opportunity in each of these indications. ARDX almo Ardelyx (ARDX) May Report Negative Earnings: Know the ... Ardelyx (ARDX) is expected to deliver a year-over-year increase in earnings on higher revenues when i t report s results for the quarter ended December 2019. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

Find the latest Ardelyx, Inc. (ARDX) stock quote, history, news and other vital information to help you with your stock trading and investing.

ARDX Stock Price and Chart — NASDAQ:ARDX — TradingView After breaking to higher ground a week ago on enormous volume, shares of ARDELYX INC - NASDAQ: ARDX find themselves in constructive consolidation mode digesting the recent run on lower volume as we can observe from the Daily chart above. Earnings Whisper Number for ARDX: Ardelyx

ARNA Discussion Board - InvestorVillage

ARDX (MC $155 M) FDA Decision for IBS-C Drug on September ... FDA Decision for IBS-C Drug (irritable bowel syndrome with constipation) on September 12, 2019 and Phase 3 readout of the AMPLIFY clinical trial for the treatment of Hyperphosphatemia also in Q3 2019 . Tenapanor has over $500 million commercial opportunity in each of these indications. ARDX almo Ardelyx (ARDX) May Report Negative Earnings: Know the ... Ardelyx (ARDX) is expected to deliver a year-over-year increase in earnings on higher revenues when i t report s results for the quarter ended December 2019. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. StockInvest.us - Stock Trading Ideas "StockInvest.us" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "StockInvest.us".

It also develops RDX013, a small molecule potassium secretagogue program for the treatment of patients with hyperkalemia. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was founded in 2007 and is headquartered in Fremont, California.